The current study was undertaken to compare the sensitivity, specificity, positive predictive value and negative predictive values of a dengue IgM rapid immunochromatography (ICT) assay with a dengue IgM capture ELISA for the detection of anti-dengue virus IgM in patients clinically suspected of having dengue fever (DF).
Introduction
Dengue fever (DF) is a mosquito-borne viral infection transmitted through Aedes aegypti and Aedes albopictus. 1 DF is caused by 4 distinct dengue virus (DENV) serotypes, namely DENV1, DENV2, DENV3 and DENV4. 2 Clinical features of DENV infection may vary between mild self limiting DF, the more severe dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). 3 Epidemic DHF first started in Manila, Philippines from 1953 to 1954 and rapidly spread to Asian regions. 4 DF is endemic in Sri Lanka and several outbreaks have been reported in the last ten years, with high morbidity and mortality rates recorded in the recent past. 5 In Sri Lanka, the laboratory diagnosis of DF is mainly by the detection of anti-dengue virus IgM antibodies using rapid immunochromatographic (ICT) assays. NS1 and dengue antibody detection are the 2 main methods used in the diagnosis of dengue infections. Although NS1 detection is available in private sector laboratories, it is not available in government hospitals for routine use. Most government hospitals also do not provide an antibody diagnostic service using ELISA based methods. However, rapid immunochromatographic (ICT) assays are being widely used in both government and private sector laboratories to provide a rapid diagnostic service.
There are many rapid IgM-based dengue diagnostic tests which are low cost, quick and easy to use. They exist in many lateral flow immunochromatographic strips formats. Most use recombinant antigens from all four dengue virus serotypes and provide results within 15 to 90 minutes. Evaluation of 4 such kits gave sensitivities ranging from 21%-99% and specificities from 77%-98% when compared with the gold standard ELISAs. 6 There is no published data on the percentage of use of these methods for the detection of antidengue IgM antibodies in Sri Lanka. There is also a serious dearth of information on the reliability of these assays in Sri Lanka.
Thus the objective of the current study was to compare the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of one rapid dengue ICT IgM assay with a dengue IgM capture ELISA for the detection of anti-dengue virus IgM in clinically suspected DF patients. All the kits used for this study were provided to THP by the Ministry of Health, Sri Lanka.
Materials and Methods
Blood samples (n=119) were collected between September 2011 and January 2012 from DF suspected paediatric and adult patients hospitalized at THP, Sri Lanka. The samples were analyzed for the presence of anti-dengue virus IgM and IgG using the rapid ICT IgM assay (Hexagon dengue, Human, Germany) and IgM capture ELISA (Panbio Diagnostics Inc, Australia).
The rapid dengue ICT IgM and IgG assay was performed at the microbiology laboratory of THP as a part of the routine diagnosis of DENV infection, and the results of the patients were issued to the wards within 2-3 hours of the test.
The ELISA test was performed using the remaining serum at the Department of Microbiology, Faculty of Medicine, University of Peradeniya. Both assays were performed in accordance with the respective manufacturer's instructions.
ICT rapid test for the detection of dengue IgG and IgM antibodies (Hexagon dengue, Human, Germany)
This rapid assay can qualitatively detect IgG and IgM to DENV in human body fluids such as serum, plasma and whole blood. According to the manufacturer, antibodies to all 4 serotypes can be detected and no false positive results were obtained with yellow fever, Japanese encephalitis, Plasmodium falciparum and Plasmodium vivax. This rapid ICT assay captures dengue-specific IgM and IgG antibodies by the antigens coated on the colloidal gold particles. The immune complexes migrate along the membrane and are captured by monoclonal anti human IgG in the first line and monoclonal anti human IgM in the second line. The excess and the non-reacted particles will be captured by the anti dengue IgG forming the control line. 
Dengue IgM capture ELISA (Panbio Diagnostics Inc, Australia)
CDC recommends ELISA IgM detection for the detection of all 4 DENV serotypes. 7 The Panbio Dengue IgM capture ELISA has been found to have high sensitivity and specificity. 8 It was therefore chosen as the comparator test for the current study of a rapid immunochromatographic method widely used in Sri Lanka.
The test was carried out following the manufacturers' instructions. Briefly, an aliquot (100 µl) of patient serum (diluted 1:100 in the diluent provided) was added to each well of the assay plate containing bound anti-human IgM which binds with human IgM in the patient's serum. The plate was incubated for 1 hour at 37°C. The assay plate was washed with wash buffer and 100 µl of previously mixed antigen-monoclonal antibody tracer solution was added.The plate was incubated for 1 hour at 37°C and washed again with wash buffer. The bound complexes were visualized by the addition of 100 µl of tetramethyl-benzidine substrate per well. After 10 min, the reaction was stopped by the addition of 100 µl of stop solution. The plates were read at 450 nm with a microtiter plate reader. The results were interpreted according to manufacturers' instructions. Positive and negative controls provided by the manufacturer were used. Sensitivity, specificity, PPV and NPV were calculated for the ICT rapid test using the results generated by the IgM capture ELISA.
Results
Of the 119 samples received by the Microbiology Laboratory during the study period, 93 samples (78.2 %) were from the paediatric wards and only 26 samples (21.9 %) were from the adult wards. When tested by IgM ELISA, 100 samples were positive and 19 samples negative for dengue IgM.
Using the rapid dengue ICT IgM assay, 80 samples were positive and 39 were negative for antidengue virus IgM. (Table 1 ). Test accuracy indices were determined by calculating the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the rapid dengue ICT IgM assay as shown in Table 2 .
Discussion
DF is considered as one of the most important vector borne infectious diseases in Sri Lanka. High morbidity and mortality caused by DF in the past has declined in recent times, possibly due to adherence to new management guidelines.
The ELISAs have been widely used in many DF endemic countries for anti-dengue virus IgM/IgG detection. The use of ELISA has the advantage of testing a large sample size at the same time. 9 However; this method requires more expensive laboratory infrastructure and expertise. Considering these factors, ELISA is considered more suitable for use in a tertiary care hospital laboratory which receives a large number of samples for routine laboratory diagnosis of DENV infections.
To meet the gap in diagnostics, in many dengue endemic developing countries, detection of DENV infection in the laboratory is carried out using the rapid ICT assays. The rapid dengue assay is designed to detect both IgM and IgG simultaneously. Based on this, the use of rapid ICT assays reduces the overall cost and the time for testing two immune markers in DF. Some manufacturers claim that these kits are also able to differentiate primary DENV infections from 10 Nevertheless, findings of Nga et al 11 show that the discrimination of acute primary and secondary DENV infection in DF is unreliable when using the rapid ICT assays.
The availability of many rapid ICT assays in the market suggests the need for validating these assays by independent bodies to determine their performance and ensure reliability of the in-use assays. In addition, these ICT assays should be regulated nationally to prevent the introduction of unregulated assays to the market. In the absence of a national regulatory system, evaluation by researchers in different locations of the country would be useful. 8 Validating widely used rapid assays for anti-dengue virus IgM detection would increase the reliability of the results and help support the clinical diagnosis. Validating rapid ICT assays are usually done by comparing the accuracy indices such as sensitivity, specificity, PPV and NPV with a known reference standard or a gold standard method. 6 Using a known reference standard method might be difficult unless routinely performed by a national laboratory for quality control of assays used in a country. Thus a centrally validated (CDC) and widely accepted ELISA method is helpful for use as a comparator to assess rapid ICT assays. 12, 13 Some studies have shown high rates of sensitivity and specificity for rapid ICT assays. 9 However, in the current study, the sensitivity and the NPV for anti-dengue virus IgM detection by the rapid ICT assay were comparatively lower than that of ELISA (Table 2) with the inference that this particular assay will give a high percentage of false negatives.
Only one rapid ICT (Hexagon dengue, Human, Germany) was tested in this study. However, there are many ICT cassettes (at least five different brands) marketed and utilized in the Sri Lankan market. There is no quality assurance programme in Sri Lanka currently for the testing and validation of imported diagnostic kits. The results of this study suggest the need for such a programme to be established so that users, including laboratories, clinicians and patients would be aware of the limitations of the test being used for diagnosis of a commonly encountered infection in Sri Lanka.
The limitations of the current study include sample size and the testing of only one rapid ICT kit.
